Charlotte Costentin

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

Étienne Garin, Lambros Tselikas, Boris Guiu et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 604 citations

Medicine, Oncology, Radiation Oncology +17

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features

Julien Caldéraro, Benoı̂t Rousseau, Giuliana Amaddeo et al. · Hepatology · 2016 · 440 citations · Full text

Medicine, Oncology, Pharmacology +17

Macrotrabecular‐massive hepatocellular carcinoma

Marianne Ziol, Nicolas Poté, Giuliana Amaddeo et al. · Hepatology · 2017 · 233 citations

Medicine, Oncology, Pathology +17

Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores

Arun J. Sanyal, Julie Foucquier, Zobair M. Younossi et al. · Journal of Hepatology · 2022 · 199 citations · Full text

Medicine, Internal Medicine, Pathology +14